THERAVANCE BIOPHARMA revenue breakdown overview

THERAVANCE BIOPHARMA revenue for the last year amounted to 52.03 M EUR, the most of which — 52.03 M EUR — came from its highest performing source at the moment, Human Therapeutics, the year earlier bringing 47.98 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought THERAVANCE BIOPHARMA 51.82 M EUR, and the year before that — 47.77 M EUR.